Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates

Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.11%. A quarter ago, it was expected that this company would post a loss of $0.36 per share when it actually produced a loss of $0.3, delivering a surprise of +16.67%.Over the last four quarters, the company ...